Review period expiry for use of 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)
4th January 2033
4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)
- 5 uses applied for by Octapharma AB and 4 other co-applicants
|
Reference of the decision |
Date of decision |
Substance name |
Holder of the authorisation |
Authorisation number |
Authorised use |
Date of expiry of review period |
|
C(2022) 1506 |
16 March 2022 |
4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO) EC No: -, CAS No:- |
Octapharma AB, Lars Forssells gata 23, SE-11275 Stockholm, Sweden Octapharma Produktionsgesel schaft Deutschland mbH, Wolfgang- Marguerre-Allee 1, 31832 Springe, Germany Octapharma S.A.S. 72 rue du Maréchal Foch, 67381 Lingolsheim, France |
REACH/22/5/0 REACH/22/5/1 REACH/22/5/2 REACH/22/5/3 |
As detergent for a virus inactivation step (solvent/detergent treatment) during the manufacture of plasma-derived and recombinant medicinal products |
4 January 2033 |